Biological Drugs Market: Global Study on Biological Drugs: North America to Witness Highest Growth by 2020
Persistence Market Research
Global Biological Drugs Market Will Reach USD 2, 87,139.7 Million in 2019: Persistence Market Research
Persistence Market Research
1
Biological Drugs Market: Global Study on Biological Drugs: North America to Witness Highest Growth by 2020 Persistence Market Research Released New Market Report "Global Market Study on Biological Drugs: North America to Witness Highest Growth by 2020� the global biological drugs market is estimated at USD 1, 61,056.5 million in 2014 and is expected to grow at a CAGR of 10.1% from 2014 to 2020, to reach an estimated value of USD 2, 87,139.7 million in 2020.
The biological drugs market is witnessing a significant growth due to the increasing prevalence of chronic diseases and increase in the global geriatric population. Biological drugs are used in treatment and prevention of various diseases such as cancer, blood-related diseases, auto-immune diseases and other medical disorders. Moreover, various government associations are also promoting the usage of biological drugs. Furthermore, advancement in biomedical sciences holds immense potential for the growth of the biologic drugs market.
However, high cost of biological drugs and patent expiry of blockbuster drugs impede growth of the biological drugs market. Moreover, the risk of adverse effects associated with biologic injectable drugs is also one of the key restraints for biological drugs market. As a result, biological drugs market is expected to grow a CAGR of about 10.1% during 2014-2020.
Browse the full Global Market Study on Biological Drugs: North America to Witness Highest Growth by 2020 report at http://persistencemarketresearch.com/market-research/global-biologicaldrugs-market.asp
North America is the largest market for biological drugs. Increased usage of biological drugs for the treatment of diseases such as cancer, diabetes and other chronic diseases are supporting the growth of the biological drugs market in the region. Moreover, several clinics in the region are focusing on biological drugs for the treatment of various chronic diseases. For instance, the American Center for Biological Medicine (ACBM) is one of the largest biological medicine clinics in the U.S.
Similarly, the European biological drugs market is growing rapidly due to increased usage of biological drugs for the treatment of various chronic diseases such as diabetes, cancer and inflammatory diseases.
Persistence Market Research
2
Biological Drugs Market: Global Study on Biological Drugs: North America to Witness Highest Growth by 2020 In Asia, low manufacturing cost is attracting many biological manufactures to invest in Asian countries, supporting the growth of the biological drugs market. Moreover, Asian governments are also supporting in growth of the biological drugs market by increased investment on biotech companies for construction of R&D and manufacturing facilities.
Novartis AG, Pfizer Inc., GlaxoSmithKline plc. and Merck & Co., Inc. are some of the leading players in the global biological drugs market. Other major players of biological drugs market include Abbott Laboratories, Biogen Idec and Amgen Inc.
The global market of biological drugs is segmented as follows: Biological Drugs Market, By Therapeutic Protein
Enbrel
Lantus
Neulasta
Avonex
NovoLog
Rebif
Humalog
Aranesp
Epogen
Levemir
Victoza
Betaseron
Neupogen
Eylea
Persistence Market Research
3
Biological Drugs Market: Global Study on Biological Drugs: North America to Witness Highest Growth by 2020
Biological Drugs Market, By Monoclonal Antibody (mAb)
Humira
Remicade
Rituxan
Avastin
Herceptin
Lucentis
Biological Drugs Market, By Vaccine
Prenvar 13
Gardasil
Fluzone
Varivax
Cervarix
Biological Drugs Market, by Geography
North America
Europe
Asia
Rest of the World (RoW)
Market History: Biological drugs are large molecules typically derived from living organisms. The biological drugs are used in the treatment and prevention of various diseases, such as blood related diseases, cancer, autoimmune diseases and other medical disorders. Globally, biological drugs market is growing rapidly due to increasing prevalence of various chronic diseases and increasing geriatric population. Additionally, various government associations are promoting the usage of biological drugs. Moreover, advancement in
Persistence Market Research
4
Biological Drugs Market: Global Study on Biological Drugs: North America to Witness Highest Growth by 2020 biomedical sciences holds immense potential for the growth of the biologic drugs market. The global biological drugs market is estimated at USD 1, 61,056.5 million in 2014 and is expected to grow at a CAGR of 10.1% from 2014 to 2020, to reach USD 2, 87,139.7 million by 2020. North America is the largest market for biological drugs. Enbrel is the largest and fastest growing therapeutic protein. In monoclonal antibody (mAb) segment, Humira is the largest and fastest growing mAb. Prevnar 13 is the largest and fastest growing vaccine. The global biological drugs market was valued at 1, 01,656.5 million in 2009 and it expanded to USD 1, 46,548.2 million in 2013 growing at a CAGR of 9.6% from 2009 to 2013.
Table of Content Chapter 1 Preface 11 1.1 Report Description 11 1.2 Report Methodology 12 1.3 Assumptions 12 Chapter 2 Market Synopsis 13 Chapter 3 Porter Five Forces Analysis 14 3.1 Bargaining power of suppliers 14 3.2 Bargaining power of buyers 15 3.3 Threat of new entrants 15 3.4 Threat of substitutes 15 3.5 Intensity of rivalry 15 Chapter 4 Industry Overview 17 4.1 Market Definition 17 4.2 Market Drivers 18 4.2.1 Increasing prevalence of chronic diseases enhance the market growth 18 4.2.2 Globally geriatric population increases the demand of biological drugs 19 4.2.3 Various government associations are promoting usage of biological drugs 20
Persistence Market Research
5
Biological Drugs Market: Global Study on Biological Drugs: North America to Witness Highest Growth by 2020 4.3 Impact analysis of Market Drivers 21 4.4 Market Restraints 21 4.4.1 High cost of biological drugs impedes market growth 21 4.4.2 Patent expiration of various blockbuster biological drugs 22 4.4.3 Risk of adverse effects associated with biological injectable medicines 22 4.5 Impact analysis of Market Restraints 23 4.6 Opportunities 24 4.6.1 Advancement in biomedical science promises to boost the development of new biological products 24 4.7 Market Trends 24 4.7.1 VEGF therapy is gaining popularity in biopharmaceutical industry 24 4.7.2 GMOs are gaining importance in biological drugs market 25 Chapter 5 Global Market Size And Forecast 26 Chapter 6 Market Size and Forecast by Therapeutic Protein 30 6.1 Enbrel 30 6.2 Lantus 33 6.3 Neulasta 35 6.4 Avonex 37 6.5 NovoLog 40 6.6 Rebif 42 6.7 Humalog 44 6.8 Aranesp 46 6.9 Epogen 48 6.10 Levemir 50 6.11 Victoza 52 6.12 Betaseron 54 6.13 Neupogen 56 6.14 Eylea 58 Chapter 7 Market Size and Forecast by mAb 60
Persistence Market Research
6
Biological Drugs Market: Global Study on Biological Drugs: North America to Witness Highest Growth by 2020 7.1 Humira 60 7.2 Remicade 63 7.3 Rituxan 65 7.4 Avastin 67 7.5 Herceptin 70 7.6 Lucentis 72 Chapter 8 Market Size and Forecast by Vaccine 74 8.1 Prenvar 13 74 8.2 Gardasil 77 8.3 Fluzone 79 8.4 Varivax 81 8.5 Cervarix 83 Chapter 9 Market Size and Forecast by Geography 85 9.1 North America 85 9.2 Europe 94 9.3 Asia 103 9.4 Rest of the World (RoW) 112 Chapter 10 Pipeline Biological Drugs 113 10.1 Biological drugs under development for auto-immune diseases 113 10.2 Biological drugs under development for blood diseases 114 10.3 Biological drugs under development for cancer and related conditions 115 10.4 Biological drugs under development for diabetes and cardiovascular diseases 116 Chapter 11 Competitive Scenario 117 11.1 Competitive Benchmarking 117 Chapter 12 Company Profiles 118 12.1 Pfizer Inc. 118 12.1.1 Company Overview 118
Persistence Market Research
7
Biological Drugs Market: Global Study on Biological Drugs: North America to Witness Highest Growth by 2020 12.1.2 Product and Services 119 12.1.3 Financial Performance 119 12.1.4 Recent Developments 120 12.2 Abbott Laboratories 122 12.2.1 Company Overview 122 12.2.2 Product and Services 123 12.2.3 Financial Performance 124 12.2.4 Recent Developments 124 12.3 Novartis AG 125 12.3.1 Company Overview 125 12.3.2 Product and Services 126 12.3.3 Financial Performance 127 12.3.4 Recent Developments 127 12.4 Eli Lilly and Company 129 12.4.1 Company Overview 129 12.4.2 Product and Services 129 12.4.3 Financial Performance 130 12.4.4 Recent Developments 130 12.5 GlaxoSmithKline plc. 131 12.5.1 Company Overview 131 12.5.2 Product and Services 131 12.5.3 Financial Performance 132 12.5.4 Recent Developments 132 12.6 Bristol-Myers Squibb Company 135 12.6.1 Company Overview 135 12.6.2 Product and Services 135 12.6.3 Financial Performance 136 12.6.4 Recent Developments 136 12.7 Merck & Co., Inc. 139 12.7.1 Company Overview 139 12.7.2 Product and Services 139 12.7.3 Financial Performance 140
Persistence Market Research
8
Biological Drugs Market: Global Study on Biological Drugs: North America to Witness Highest Growth by 2020 12.7.4 Recent Developments 140 12.8 Amgen Inc. 142 12.8.1 Company Overview 142 12.8.2 Product and Services 142 12.8.3 Financial Performance 143 12.8.4 Recent Developments 143 12.9 Baxter International Inc. 145 12.9.1 Company Overview 145 12.9.2 Product and Services 145 12.9.3 Financial Performance 146 12.9.4 Recent Developments 146 12.10 Biogen Idec 149 12.10.1 Company Overview 149 12.10.2 Product and Services 149 12.10.3 Financial Performance 150 12.10.4 Recent Developments 150 About Us: Persistence Market Research is a global market research firm specializing- syndicated research, custom research, and consulting services
At Persistence Market Research (PMR), we are in the business of accelerating your business. As a fullservice market research firm, we stand committed to bringing more accuracy and speed to your business decisions. From ready-to-purchase market research reports to customized global research solutions, our engagement models are highly flexible without compromising on our deep-seated research values. Briefly stated, our mission is to give you access to forecasts and trends analyses that put you on the path to profitability.
PMR’s Services Go Beyond Gleaning Data
Most enterprises believe that IT and databases are enough to make an accurate decision. While we do not dispute that, consider this: How long does it take to make an accurate and strategic million-dollar decision? We strive to deliver both even with demanding deadlines.
Persistence Market Research
9
Biological Drugs Market: Global Study on Biological Drugs: North America to Witness Highest Growth by 2020 Contact Us: Addie Thomes 305 Broadway, 7th Floor, New York City, NY 10007, United States. Tel: No. +1-646-568-77 USA/Canada Toll Free Number.1-800-961-0353 E-mail: Sales@persistencemarketresearch.com web: http://www.persistencemarketresearch.com/ Published Reports: http://www.persistencemarketresearch.com/market-reports.asp Blog: http://persistencemarketresearchblog.wordpress.com/
Persistence Market Research
10